Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Eculizumab by Alexion Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute...
Eculizumab by Alexion Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Eculizumab by Alexion Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury: Likelihood of Approval
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute...
Eculizumab by Alexion Pharmaceuticals for Subarachnoid Hemorrhage: Likelihood of Approval
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Subarachnoid Hemorrhage. According to GlobalData, Phase...